TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
Q2 2026 vs. Q1 2026
How the institutions holding TriSalus Life Sciences, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 84 | 2 | 78 | −4 |
| Shares | 20.9M | 749 | 21.8M | +904.4K (+4.3%) |
| Value | $83.4M | $3.00K | $99.0M | +$15.6M (+18.7%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lionhunter Capital Management, LLC | 300,275 | $1.37M | 0.62% |
| AQR Capital Management LLC | 117,977 | $536.8K | 0.00% |
| MetLife Investment Management | 30,413 | $138.4K | 0.00% |
| Intech Investment Management LLC | 10,485 | $47.7K | 0.00% |
| Cura Wealth Advisors, LLC | 10,000 | $35.6K | 0.02% |
| Strive Financial Group ,LLC | 2,289 | $10.4K | 0.00% |
| Royal Bank of Canada | 1,834 | $8.00K | 0.00% |
| Clearstead Advisors, LLC | 100 | $455 | 0.00% |
| IFP Advisors, Inc | 51 | $232 | 0.00% |
| Fortitude Family Office, LLC | 28 | $127 | 0.00% |
| SJS Investment Consulting Inc. | 12 | $55 | 0.00% |
Sold out (15)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| AWM Investment Company, Inc. | 2,079,105 | $8.32M |
| Wasatch Advisors Inc | 1,437,960 | $5.75M |
| Empire Financial Management Company, LLC | 300,275 | $1.20M |
| Apis Capital Advisors, LLC | 180,000 | $720.0K |
| Intrust Bank NA | 66,000 | $264.0K |
| Formula Growth Ltd | 50,000 | $200.0K |
| Renaissance Technologies LLC | 30,900 | $123.6K |
| Ghisallo Capital Management LLC | 25,000 | $100.0K |
| Man Group plc | 23,358 | $93.4K |
| Susquehanna International Group, LLP | 12,994 | $52.0K |
| GAMMA Investing LLC | 386 | $1.54K |
| Rachor Investment Advisory Services, LLC | 51 | $204 |
| MAI Capital Management | 15 | $60 |
| Root Financial Partners, LLC | 12 | $48 |
| Advisory Services Network, LLC | 7 | $28 |
Not filed for Q2 2026 yet (2)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 747 | $2.99K |
| Sunbelt Securities, Inc. | 2 | $8 |